Analysts Viewpoint
CHRS’s latest rating updates from top analysts.
Coherus Oncology Inc’s filing revealed that its Director Wahlstrom Mats unloaded Company’s shares for reported $73881.0 on May 23 ’25.
Menu
Coherus Oncology Inc’s filing revealed that its Director Wahlstrom Mats unloaded Company’s shares for reported $73881.0 on May 23 ’25.
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Coherus Oncology
Coherus Oncology Inc’s filing revealed that its Director Wahlstrom Mats unloaded Company’s shares for reported $73881.0 on May 23 ’25.
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Coherus Oncology
Coherus Oncology Inc’s recent filing unveils that its Director Wahlstrom Mats unloaded Company’s shares for reported $73881.0 on May 23
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Coherus Oncology
Coherus Oncology Inc’s recently made public that its Director Wahlstrom Mats unloaded Company’s shares for reported $73881.0 on May 23
Coherus Oncology Inc’s filing revealed that its Director Wahlstrom Mats unloaded Company’s shares for reported $73881.0 on May 23 ’25.
Coherus Oncology Inc’s recently made public that its Director Wahlstrom Mats unloaded Company’s shares for reported $73881.0 on May 23